Reviewer | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
---|---|---|---|---|---|---|---|---|
Tarek F. Antonios | St George’s, University of London (United Kingdom) | None | None | None | None | None | None | None |
Michel Baum | University of Texas Southwestern Medical Center at Dallas | None | None | None | None | None | None | None |
Hui Hu | Brigham and Women’s Hospital | None | None | None | None | None | None | None |
Maris Laan | University of Tartu (Estonia) | Estonian Research Agency (grant EAG112 “Maternal Serum Based Multimarker Test for the Risk Assessment to Develop Preeclampsia: Translation to the Clinic [ESTPRE study]”)† | None | None | None | None | None | None |
Anne M. Nuyt | Université de Montréal (Canada) | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
Significant.